Digital healthcare is increasingly relying on Large Language Models for tasks ranging from report drafting to diagnostic image analysis. To keep track of these automatically generated contributions, watermarks are used—techniques that insert imperceptible marks into text or multimodal outputs. But what happens when those marks alter clinical meaning? A new study involving 11 LLMs and 7 VLMs with 5 watermarking schemes shows that degradation is real, and the usual evaluation toolbox can't see it.

The researchers built an audit pipeline validated by human experts to examine medical reasoning quality, terminological precision, and induced hallucinations. The results are alarming: watermarks introduce lexical corruption, invent non-existent medical terms, and amplify misattribution or omission of image findings. The key point isn't just that performance drops, but that aggregate metrics—the kind normally used to compare models—systematically hide these flaws. A model may appear acceptable on a general-purpose benchmark while, in a clinical setting, producing potentially lethal errors.

This study highlights a tension well known to those designing on-premise AI infrastructures: the need for traceability and regulatory compliance clashes with the demand for absolute accuracy. In healthcare, hospitals and clinics running models locally—so as not to hand sensitive data to external clouds—must ensure that every automated report is identifiable as LLM-generated. But if the very act of marking the output degrades its quality to the point of false negatives or wrong diagnoses, the trade-off becomes untenable.

The absence of domain-specific analyses in current benchmarks is a structural flaw reminiscent of problems already seen with language models applied to regulated sectors: validation on generic tests, deployment in critical contexts, and failures surfacing only after damage is done. For those designing on-premise inference pipelines, this means the selection of a watermark cannot be an afterthought, an innocent plug-in. It must be integrated into the model's fine-tuning and validation phase, using real clinical metrics.

Data sovereignty adds another layer of complexity. In a self-hosted environment, the operator has full control over the model and can decide whether and how to apply watermarks, but might also be tempted to disable them to preserve diagnostic quality. This creates a legal vulnerability: without watermarks, how do you prove in an audit that a report was generated by an LLM? The alternative—keeping watermarks on and accepting a higher rate of clinical hallucinations—is ethically problematic and technically retrograde.

The study suggests that domain-specific evaluation is not optional but a prerequisite for the safe deployment of watermarked models in medicine. It also implies that companies pushing traceability solutions need to rethink watermark design, perhaps making them less semantically invasive, or develop clinical tests that become reference standards. For those currently deciding deployment architectures in healthcare, the message is clear: without dedicated medical benchmarks, any quality certification based on aggregate metrics is worthless. And every day of delay in creating clinical standards for watermarks is a day when a model might misdiagnose "because of the mark".